New drugs

New obesity treatment targets appetite and reward pathways in the brain

New obesity treatment targets appetite and reward pathways in the brain

Mysimba (naltrexone/bupropion) can be used alongside...

Eluxadoline: first treatment option for IBS patients with diarrhoea

Eluxadoline: first treatment option for IBS patients with diarrhoea

Truberzi (eluxadoline) is a new orally administered...

New antibody prevents recurrence of Clostridium difficile infection

New antibody prevents recurrence of Clostridium difficile infection

Zinplava (bezlotoxumab) is a human monoclonal antibody...

AirFluSal MDI: a new LABA/corticosteroid inhaler

AirFluSal MDI: a new LABA/corticosteroid inhaler

AirFluSal MDI (salmeterol/fluticasone) is indicated...

Inhaler options multiply with launch of new salmeterol/fluticasone MDI

Inhaler options multiply with launch of new salmeterol/fluticasone MDI

Sereflo (salmeterol/fluticasone) is indicated for adults...

Methotrexate available in button-free auto-injector

Methotrexate available in button-free auto-injector

Rheumatoid arthritis patients who struggle to use existing...

Baricitinib: oral rheumatoid arthritis treatment in new drug class

Baricitinib: oral rheumatoid arthritis treatment in new drug class

Olumiant (baricitinib) 4mg tablets are now available...

Tofacitinib: new type of rheumatoid arthritis treatment launches

Tofacitinib: new type of rheumatoid arthritis treatment launches

Xeljanz (tofacitinib) is a new oral treatment option...

Alternative salmeterol/fluticasone dry powder inhaler for asthma and COPD

Alternative salmeterol/fluticasone dry powder inhaler for asthma and COPD

Aerivio Spiromax provides the same metered dose of...

New combination antibiotic for serious infections

New combination antibiotic for serious infections

Zavicefta (ceftazidime/avibactam) is a new combination...

Register or Subscribe to MIMS

GPs can get MIMS print & online and GPonline for free when they register online – take 2 minutes, and make sure you get your free MIMS access! If you're not a GP, you can subscribe to MIMS for full access.

Register or subscribe

MIMS bulletins

News and updates straight to your inbox.

Prescribing Update: Fortnightly news bulletin
Alert:
Urgent prescribing updates
Spotlight: Disease-themed monthly round-up

Sign me up

MIMS Dermatology

Read the latest issue online exclusively on MIMS Learning.

Read MIMS Dermatology

MIMS Adviser

Especially created for prescribing influencers.

Request free copy

Mobile apps

MIMS: access the full drug database and quick-reference tables on the go

MIMS Diagnosis and Management: concise information on signs and symptoms, investigations and diseases